The effect of Colestimide on the lowering activity of LDL-C and visceral fat in patients with hypercholesterolemia

Trial Profile

The effect of Colestimide on the lowering activity of LDL-C and visceral fat in patients with hypercholesterolemia

Recruiting
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 12 May 2016

At a glance

  • Drugs Colestilan (Primary) ; Pravastatin
  • Indications Hypercholesterolaemia
  • Focus Biomarker; Therapeutic Use
  • Most Recent Events

    • 04 Feb 2009 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top